Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism
ConclusionTo our knowledge, this is the largest clinical study to date showing that patients with obesity can be effectively and safely treated with a DOAC compared with warfarin for acute VTE. Thus, DOACs should be considered as a reasonable alternative to warfarin for treatment of acute VTE in obese patients.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: James C. Coons,
Lauren Albert,
Andrea Bejjani,
Carlo J. Iasella Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
More News: Academia | Bleeding | Chronic Kidney Disease | Coumadin | Drugs & Pharmacology | Eating Disorders & Weight Management | Obesity | Pradaxa | Pulmonary Thromboembolism | Study | Thrombosis | Urology & Nephrology | Warfarin